PortfoliosLab logoPortfoliosLab logo
ISIN
US2290503075
CUSIP
229050307
IPO Date
Mar 15, 2005

Highlights

Market Cap
$823.31M
Enterprise Value
$785.11M
EPS (TTM)
$1.54
PE Ratio
10.70
Total Revenue (TTM)
$182.94M
Gross Profit (TTM)
$86.33M
EBITDA (TTM)
-$16.70M
Year Range
$6.16 - $16.70
Target Price
$12.50
ROA (TTM)
10.10%
ROE (TTM)
15.58%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Cryoport, Inc.

Performance

CYRX Performance Chart

Cryoport, Inc. (CYRX) is up 71.9% since the beginning of the year. At $17 per share, CYRX is trading just below its 52-week high of $17. Investors who bought $1,000 worth of CYRX shares 5 years ago would now be looking at an investment worth $293.


Loading charts...

S&P 500 Index

Returns By Period

Cryoport, Inc. (CYRX) has returned 71.88% so far this year and 182.53% over the past 12 months. Looking at the last ten years, CYRX has achieved an annualized return of 25.82%, outperforming the S&P 500 Index benchmark, which averaged 13.66% per year.


Cryoport, Inc.

1D
4.83%
1M
61.61%
YTD
71.88%
6M
75.35%
1Y
182.53%
3Y*
-5.64%
5Y*
-21.77%
10Y*
25.82%

Benchmark (S&P 500 Index)

1D
-0.74%
1M
4.90%
YTD
10.35%
6M
10.28%
1Y
26.52%
3Y*
20.83%
5Y*
12.30%
10Y*
13.66%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CYRX Monthly Returns History

Based on dividend-adjusted daily data since Jan 2, 2009, CYRX's average daily return is +0.15%, while the average monthly return is +2.06%. At this rate, an investment would double in approximately 2.8 years.

Historically, 50% of months were positive and 50% were negative. The best month was Jan 2010 with a return of +102.4%, while the worst month was Feb 2010 at -68.1%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 7 months.

On a daily basis, CYRX closed higher 46% of trading days. The best single day was Mar 11, 2025 with a return of +41.5%, while the worst single day was Feb 25, 2010 at -49.6%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-0.94%-11.46%-1.66%23.91%52.92%5.16%71.88%
2025-3.08%-26.13%9.16%-8.22%7.71%24.13%-1.74%20.87%7.00%-2.53%4.11%-0.21%23.39%
2024-6.33%21.78%0.17%-8.53%-36.50%-32.78%33.57%0.98%-12.98%-17.88%6.31%9.89%-49.77%
202331.59%-5.12%10.80%-12.33%-12.50%-6.30%-6.84%-12.26%-2.77%-29.25%44.54%10.49%-10.72%
2022-29.41%-17.81%1.69%-35.38%12.81%21.73%20.08%-12.20%-25.41%13.96%-28.85%-12.15%-70.68%
202155.42%-12.84%-12.50%8.77%-1.15%12.84%-2.19%3.00%4.62%22.60%-18.52%-10.94%34.85%

Benchmark Metrics

Cryoport, Inc. has an annualized alpha of 28.50%, beta of 0.94, and R2 of 0.03 versus S&P 500 Index. Calculated based on daily prices since January 05, 2009.

  • This stock participated in 117.86% of S&P 500 Index downside but only 35.25% of its upside - more exposed to losses than it benefited from rallies.
  • R2 of 0.03 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
28.50%
Beta
0.94
0.03
Upside Capture
35.25%
Downside Capture
117.86%

Return for Risk

Risk / Return Rank

CYRX ranks 92 for risk / return — in the top 92% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.


CYRX Risk / Return Rank: 9292
Overall Rank
CYRX Sharpe Ratio Rank: 9393
Sharpe Ratio Rank
CYRX Sortino Ratio Rank: 9393
Sortino Ratio Rank
CYRX Omega Ratio Rank: 8989
Omega Ratio Rank
CYRX Calmar Ratio Rank: 9393
Calmar Ratio Rank
CYRX Martin Ratio Rank: 9191
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Cryoport, Inc. (CYRX) and compare them to S&P 500 Index.


CYRXBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

2.74

2.24

+0.49

Sortino ratio

Return per unit of downside risk

3.59

3.07

+0.52

Omega ratio

Gain probability vs. loss probability

1.42

1.41

+0.02

Calmar ratio

Return relative to maximum drawdown

5.83

2.93

+2.90

Martin ratio

Return relative to average drawdown

13.46

13.52

-0.06

Dividends

Dividend History


Cryoport, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Cryoport, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Cryoport, Inc. was 99.06%, occurring on Feb 9, 2016. The portfolio has not yet recovered.

The current Cryoport, Inc. drawdown is 85.52%.


Related event

Drawdown

Fall

Recovery

Underwater

2016 bear market2016
-99.06%Feb 2016
6y 19d
16y 4moJan 2010 - now
Financial crisis2007–2009
-54.88%Jul 2009
1mo 19d6mo 4d
7mo 23dMay 2009 - Jan 2010
Financial crisis2007–2009
-40.00%Mar 2009
25d18d
1mo 13dFeb 2009 - Mar 2009
Financial crisis2007–2009
-25.93%Jan 2009
18d14d
1mo 2dJan 2009 - Feb 2009
Financial crisis2007–2009
-25.45%Apr 2009
10d18d
28dApr 2009 - May 2009

Drawdown Indicators


CYRXBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-99.06%

-56.78%

-42.28%

Max Drawdown (1Y)

Largest decline over 1 year

-31.50%

-9.10%

-22.40%

Max Drawdown (3Y)

Largest decline over 3 years

-79.13%

-18.90%

-60.23%

Max Drawdown (5Y)

Largest decline over 5 years

-94.36%

-25.43%

-68.93%

Max Drawdown (10Y)

Largest decline over 10 years

-94.36%

-33.92%

-60.44%

Current Drawdown

Current decline from peak

-85.52%

-0.74%

-84.78%

Average Drawdown

Average peak-to-trough decline

-83.01%

-10.72%

-72.29%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.62%

1.97%

+11.65%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Cryoport, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Cryoport, Inc. is priced in the market compared to other companies in the Integrated Freight & Logistics industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for CYRX, comparing it with other companies in the Integrated Freight & Logistics industry. Currently, CYRX has a P/E ratio of 10.7. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for CYRX relative to other companies in the Integrated Freight & Logistics industry. Currently, CYRX has a P/S ratio of 4.5. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for CYRX in comparison with other companies in the Integrated Freight & Logistics industry. Currently, CYRX has a P/B value of 1.7. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with CYRX

Add Cryoport, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with CYRX